LipoScience has entered into a research agreement with Duke University School of Medicine to identify cardiovascular risk factors to be used alone or in combination with other clinical measures to improve stratification and management of acute coronary syndrome. The agreement encompasses studies to be performed with Duke’s CathGen (CatheterizationGenetics) and other patient registries.
Under terms of the deal, Lipo-Science will perform NMR Lipo-Profile test analysis and other metabolite assays of blood samples from the registries to study the relationship between lipoproteins and acute coronary syndrome in these patient populations.
The CathGen registry was collected between 2001 and 2011 to create combined biochemical and clinical bio and data repositories for cardiovascular disease research. The data repositories contain genetic information, blood biochemical marker data, clinical information, and clinical endpoint followup.
LipoScience, 919-212-1999